Multiparametric MR of the prostate provides an extremely accurate diagnosis and offers an excellent negative predictive value for cancers which biopsies struggle to detect.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Combined with biopsies they consolidate both positive and negative biopsy results and allow patients to be offered more appropriate treatments (active monitoring, radical treatment in full knowledge of the topography of the lesions involved, or local treatment, etc.). The investigation does not require advanced equipment and can be carried out in any MR centre although it needs to follow a technical protocol described in the European guidelines (ESUR 2012). Interpretation should be standardized to facilitate communication of clear and consistent information between practitioners.
Puech P, Villers A, Ouzzane A, Lemaitre L. Are you the author?
Department of renal-urological and ENT radiology, Lille university hospital, CHRU Claude-Huriez, 1, rue Michel-Polonovsk, 59037 Lille cedex, France; Department of genitourinary and ENT radiology, Lille University Hospital, CHRU de Lille, 1, rue Michel-Polonovsk, 59037 Lille cedex, France.
Reference: Diagn Interv Imaging. 2014 Jul-Aug;95(7-8):743-52.